Skip to Main Content

Firm News

Tod Northman Comments to Rx Data News on AI's Potential Impact on Clinical Trials

June 2019 - Rx Data News
Social Logo Social Logo Social Logo

Tod Northman provided "Monthly Deep Focus" commentary to Rx Data News in its issue dedicated to artificial intelligence (AI). Commenting on the impact that AI will have on clinical trials, Tod said, "The increasing complexity of clinical drug trials in the United States has resulted in the cost and time to commercialize a drug to skyrocket. In this context, artificial intelligence appears perfectly timed to help reduce the costs and time for clinical trials while potentially providing better results."

Read more of Tod's commentary here.

Driverless
A podcast that analyzes legal issues surrounding autonomous vehicles.
ERISA
Perspectives on employee benefits, executive compensation and ERISA litigation to help you attract and retain talent.
lingua negoti
The language of business.
Ohio Environmental
Insights and commentary for the business and legal community.